Rigosertib for RDEB-SCC

Clinical trial NCT03786237 · COMPLETED

Trial details

NCT number: NCT03786237
Sponsor: Prof. Johann Bauer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa Dystrophica Squamous Cell Carcinoma

Start date: 2021-04-12
Primary completion: 2025-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.